Mutations in KRAS drive the oncogenic phenotype in a variety of tumors of epithelial origin. The NF-κB transcription factor pathway is important for oncogenic RAS to transform cells and to drive tumorigenesis in animal models. Recently TAK1, an upstream regulator of IKK, which controls canonical NF-κB, was shown to be important for chemoresistance in pancreatic cancer and for regulating KRAS+ colorectal cancer cell growth and survival. Here we show that KRAS+ upregulates GSK-3α leading to its interaction with TAK1 to stabilize the TAK1/TAB complex to promote IKK activity. Additionally, GSK-3α is required for promoting critical non-canonical NF-κB signaling in pancreatic cancer cells. Pharmacologic inhibition of GSK-3 suppresses growth of human pancreatic tumor explants, consistent with the loss of expression of oncogenic genes such as c-myc and TERT. These data identify GSK-3α as a key downstream effector of oncogenic KRAS via its ability to coordinately regulate distinct NF-κB signaling pathways.
<p>PDF file - 181K, Left: Kras regulates TAK1 levels. HKRAS cells were transiently transfected with non-targeting or Kras siRNA for 72 hours. TAK1 was immunoprecitated from whole cell extracts and immunoblotted for specified antibodies. Right: TAK1 inhibition induces apoptosis. MiaPaCa-2 cells were treated with the TAK1 inhibitor, 5Z-7-oxozaenol at indicated concentrations for 24 hours. Whole cells extracts were immunoblotted with specified antibodies.</p>
<p>PDF file - 308K, Left: AR-A014418 inhibits GSK-3 activity in a dose dependent mannerPanc-1 cells were treated with increasing concentrations of GSK-3 inhibitor, AR-A014418, like in Fig.1A. Whole cells extracts were prepared and immunoblotted for specified antibodies. p-Glycogen synthase is a downstream substrate of GSK-3 and thus an indicator of its kinase activity. Right: GSK-3 regulates apoptosis in MiaPaCa-2 cells. . Panc-1 and MiaPaCa-2 cells were transiently transfected with indicated siRNAs for 72 hours. Whole cell extracts were immunoblotted for specified antibodies.</p>
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.